EX-99.1 2 dentsply8kq12026ex991.htm EX-99.1 Document Dentsply Sirona Reports First Quarter 2026 Results News Summary • Reported net sales of $880 million • Delivered GAAP gross margin of 48.5%, GAAP net loss per share of ($0.05) • Achieved adjusted gross margin of 50.7%, adjusted EBITDA margin of 14.7%, adjusted EPS of $0.27 • Launched Smart View-Detect, the world's first FDA-cleared, AI-enabled diagnostic aid designed to identify teeth with periapical radiolucencies (PARL) in CBCT scans, now also CE-marked for use across Europe • Continued to penetrate connected technology solutions market with new Atlanta Dental Supply distributor agreement • Installed first CEREC® system under the new Benco Dental distribution agreement, marking an important early milestone • Began implementing new capital allocation strategy by reducing debt, managing liquidity, and improving working capital • Reiterated 2026 outlook for net sales and adjusted EPS Charlotte, N.C., May 5, 2026 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026. “We are executing our Return-to-Growth Action Plan as expected…
Open exhibit ↗Current Report · Items 2.02, 9.01 · 8-K
DENTSPLY SIRONA Inc.
XRAYNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On May 5, 2026, DENTSPLY SIRONA Inc. (the “Company”) issued a press release regarding the Company’s financial results for its first fiscal quarter ended March 31, 2026. A copy of the Company’s press release is furnished as Exhibit 99.1 and an updated GAAP to Non-GAAP reconciliation is furnished as Exhibit 99.2.…
Company context
Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona's innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company's shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Current securities
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Filed exhibits (2)
EX-99.2 3 dentsply8kq12026ex992.htm EX-99.2 Document Updated GAAP to Non-GAAP Reconciliations Beginning in fiscal year 2026, the Company updated its definition of Adjusted Net Income (Loss), a non-GAAP financial measure, to include adjustments for certain significant and discrete tax items, including benefits and provisions related to changes in the realization of deferred tax assets and tax credit carryforwards, as well as other tax‑related items that affect comparability and are not considered part of the Company’s core operational performance. Management believes these changes provide investors with a view of continuing core operations without the effects of these items, which may vary for reasons unrelated to overall operating performance. As a result of this definition update, the Company has updated historical Adjusted Net Income (Loss), Adjusted EBITDA, and Adjusted Earnings Per Share information for prior periods to conform to current period presentation. The accompanying tables presents historical tables and reconciliations reflecting the updated definition. These updates do not impact previously reported gross profit, operating (loss) income, (benefit) provision fo…
Open exhibit ↗